Earningsreport

Q1/2023 3/31/2023 EPS -0.420 ZacksConsensus -0.430 ActVsEst 0.010 - Beat

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations